{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_references_@count in root_references_@count (approximate match)
Status:
Possibly Marketed Outside US
Source:
Moderna COVID-19 Vaccine by Moderna US, Inc.
(2023)
Source URL:
First approved in 2023
Source:
Moderna COVID-19 Vaccine by Moderna US, Inc.
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:flurimedrimer (<sup>18</sup>F) [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
USAN:PHEMFILCON A [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03435640: Phase 1/Phase 2 Interventional Terminated Melanoma
(2018)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:evexomostat [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:acetylcysteine zidrimer [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03358810: Not Applicable Interventional Completed Dysphagia Following Cerebral Infarction
(2018)
Source URL:
Class:
POLYMER
Status:
Excipient
Source:
9.2mg ORAL TABLET, EXTENDED RELEASE
Source URL:
Class:
POLYMER
Status:
Designated
Source:
FDA ORPHAN DRUG:511215
Source URL:
Class:
POLYMER
